Evaluation of Sentinel Lymph Node Biopsy After Primary Chemotherapy as Part of De-Escalation of Breast Cancer Treatment
Background: Sentinel lymph node biopsy (SLNB) after primary chemotherapy for node-positive breast cancer patients has been gaining popularity as part of the de-escalation of treatment. Aim: The 1ry aim was to assess the surgical outcome of node-positive patients who received primary chemotherapy fo...
Main Authors: | Mohamed I. AbdelAziz, Sherif Monib |
---|---|
Format: | Article |
Language: | English |
Published: |
Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine
2021-12-01
|
Series: | Research in Oncology |
Subjects: | |
Online Access: | https://resoncol.journals.ekb.eg/article_214163_82c5c760159d61944e03f370bb8a9919.pdf |
Similar Items
-
Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
by: Khadidja Brahmi, et al.
Published: (2017-06-01) -
A Case of Anaphylaxis to Patent Blue in a Patient with Sentinel Lymph Node Excision
by: Stefanie Aurich, et al.
Published: (2017-12-01) -
The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review
by: Giulia Ferrarazzo, et al.
Published: (2023-09-01) -
Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study
by: Andrzej Kurylcio, et al.
Published: (2021-07-01) -
Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer
by: Joseph Lin, et al.
Published: (2020-12-01)